Invention Grant
- Patent Title: Crystalline bis- and tris-hydrochloride salt of elamipretide
-
Application No.: US16866054Application Date: 2020-05-04
-
Publication No.: US11261213B2Publication Date: 2022-03-01
- Inventor: Scott M. Duncan
- Applicant: Stealth BioTherapeutics Inc.
- Applicant Address: US MA Needham
- Assignee: Stealth BioTherapeutics Inc.
- Current Assignee: Stealth BioTherapeutics Inc.
- Current Assignee Address: US MA Needham
- Agency: Foley Hoag LLP
- Agent Dana M. Gordon; Daniel M. Lewallen
- Main IPC: C07K5/00
- IPC: C07K5/00 ; C07K5/11 ; C07K1/14
Abstract:
Disclosed are crystalline forms of the bis- and tris-(hydrochloride) salts of D-Arg-Tyr(2,6-DiMe)-Lys-Phe-NH2, which is also known as MTP-131.
Public/Granted literature
- US20210061853A1 CRYSTALLINE BIS- AND TRIS-HYDROCHLORIDE SALT OF ELAMIPRETIDE Public/Granted day:2021-03-04
Information query
